The goal of genome-wide association studies (GWASs) is to discover genetic variants associated with diseases/traits. Replication is a common validation method in GWASs. We regard an association as true finding when it shows significance in both primary and replication studies. A question worth pondering is what is the probability of a primary association (i.e. a statistically significant association in the primary study) being validated in the replication study? This article systematically reviews the answers to this question from different points of view. As Bayesian methods can help us integrate out the uncertainty about the underlying effect of the primary association, we will mainly focus on the Bayesian view in this article. We refer the Bayesian replication probability as the replication rate (RR). We further describe an estimation method for RR, which makes use of the summary statistics from the primary study. We can use the estimated RR to determine the sample size of the replication study and to check the consistency between the results of the primary study and those of the replication study. We describe an R-package to estimate and apply RR in GWASs. Simulation and real data experiments show that the estimated RR has good prediction and calibration performance. We also use these data to demonstrate the usefulness of RR. The R-package is available at http://bioinformatics.ust.hk/RRate.html.
Introduction
The goal of genome-wide association studies (GWASs) is to detect genetic variants associated with diseases/traits by genotyping single nucleotide polymorphisms (SNPs) in different individuals [1] . Compared with traditional candidate gene studies based on gene function and pathway information [2] , GWASs avoid selection bias by genotyping a dense set of SNPs across the whole genome. Also, GWASs are more powerful than linkage analysis in detecting genetic variants contributing to disease risk with modest effect [3] . Since the first GWAS on agerelated macular degeneration [4] , there have been about 2000 GWASs reported so far, with 14 609 associations showing genome-wide significance (P-value 5 Â 10 À8 ) for 756 different diseases/traits [5] . Replication is a commonly used validation method in scientific discoveries [6, 7] . We commonly call a study used for discovery 'the primary study' and a study used for validation 'the replication study ' . In GWASs, we regard an association as a true finding with high confidence when it shows significance in both the primary and replication studies [8, 9] . Suppose the type I error rates in the primary study and the replication study are a 1 and a 2 , respectively. The probability of observing more extreme statistics is below showing significance in the same direction in both the primary and replication studies are replicated.) As this is a low probability, there is a high confidence that the replicable association is a true finding.
Even when a primary association (i.e. statistically significant association in the primary study) is true, it is only replicated with a certain probability. This is because the strengths of associations are subject to random variability owing to random sampling, confounding effects and measurement errors [10] . Given information from the primary study, researchers would like to know how probable it is that a primary association will be validated in the replication study. To answer this question, we need a systematic study of the behavior of primary associations in replication studies.
Recently, Science published an open empirical study of reproducibility in psychology, called the Reproducibility Project [11] . Researchers tried to replicate 100 empirical studies from three top psychology journals using high-powered designs, but only 36 of them had significant results (P-value 0.05). This 'replication crisis' has highly stressed the importance of studying the probability of replicating a significant association in different disciplines. Currently, there are few studies to quantify replication probability of a significant association. Jaffe et al. (2013) [12] gives an example to estimate the probability of replicating results in a gene-set analyses using bootstrap method.
The aim of this article is to systematically study primary positives in the replication study setting of GWASs and to review answers to the replication question from different points of view. As Bayesian methods can help us integrate out the uncertainty about the underlying effect of the primary association, we will mainly focus on the Bayesian view in this article. We refer the Bayesian replication probability as the replication rate (RR). We further describe an estimation method for RR when the summary statistics of the primary study are available. We demonstrate the two applications of RR:
1. To determine the sample size of the replication study (i.e. how many individuals are needed in the replication study to achieve a certain probability of replicating primary associations?). 2. To check the consistency between the results of the primary study and those of the replication study (i.e. are the results of the replication study consistent with RR values estimated from the primary study?). We use the Hosmer-Lemeshow test [13] in this application.
The rest of this article is organized as follows. In the next section, we will first review the answers to the replication question from the frequentist and Bayesian view. Then we will give the mathematical definitions of RR. We will also derive the relationship among the local false discovery rate (lfdr) [14] , power and RR. In the 'Estimation of RR' section, we will describe how to estimate RR using the Bayesian framework with a two-component mixture prior. In the 'Applications of RR' section, we will show the two applications of RR. In the 'Software' section, we will describe an R-package to estimate and apply RR in GWASs. In the 'Performance and applications of the RR with simulation and real data' section, we will first use simulation experiments to illustrate that the estimated RR has good prediction and calibration performance when data agree with model assumptions. Then we will show the empirical results using type 2 diabetes (T2D) data from the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) consortium [15] and total cholesterol (TC) data from the Global Lipids Genetics Consortium (GLGC) [16] . The experiments also demonstrate the usefulness of RR. In the 'Discussion' section, we will discuss the limitations of current modeling and estimation method, and these provide guidance for the future work. The 'Conclusion' section concludes the article.
Definition of RR
As an illustration, we use a log(OR) test to identify associations. Here log(OR) stands for the logarithm of the odds ratio. We can easily generalize the model to quantitative traits with simple linear regression. In the 'Performance and applications of the RR with simulation and real data' section, we give an example of RR estimation for GWASs with a quantitative trait.
Let us assume study j (j ¼ 1,2 denoting primary study and replication study, respectively) has n ðjÞ individuals, where n ðjÞ 0 of them are controls and n ðjÞ 1 are cases. The number of SNPs is m. We use p 0 to denote the proportion of null SNPs, which have no association with the disease.
For each SNP, we use A to represent the non-effect allele and a to denote the effect allele. Table 1 shows a contingency table  of alleles. Using the contingency table, we can 
The true effect size l is ordinarily unknown. Using Woolf's method [17] , we can approximate the asymptotic standard error of b l ðjÞ (denoted as r ðjÞ ) as follows: 
The null and alternative hypotheses are
and the corresponding test statistic is z ðjÞ ¼ b l ðjÞ =r ðjÞ . Let us assume the significance levels in the two studies are a 1 and a 2 , respectively. As we use a two-sided test in the primary study, a SNP showing an association with the disease has an absolute value of its z-value that is larger than z a1=2 , i.e. jz ð1Þ j > z a1 =2 , where z u is the upper u quantile of the standard normal distribution (0 u 0.5). For the association validated in the replication study, the z-value should be consistent with the z-value in the primary study. Thus, z ð2Þ should have the same sign as z ð1Þ and should also be larger than z a2 =2 in terms of absolute value, i.e. sgnðz ð1Þ Þz ð2Þ > z a2=2 , where the sign function reads 
We assume the replication study is collected independently of the primary study. For a significant association in the primary study (i.e. jz ð1Þ j > z a1 =2 ), we want to know what is the probability of it being validated in the replication study? From a frequentist point of view, this replication probability is the proportion of this primary association being validated in multiple independent replication studies with the same setting. If the primary association is a false-positive finding, the replication probability is just the type I error rate a 2 =2. If the primary association is a true finding, then the replication probability is the power of replicating this association, which depends on the true effect size l. 
We do not know whether the primary association is a true finding, and we also do not know what the true effect size is if it is a true finding. In other words, there is uncertainty in answering our major question with the frequentist replication probability.
For this reason, we will focus on the Bayesian replication probability RR. We define RR as
which removes the dependence of the replication probability on the underlying true status and effect size of the primary association. We can view RR as the estimator of the frequentist replication probability in terms of minimizing the Bayes risk. We derive the relationship among the lfdr of the primary study lfdr ð1Þ , the power of the replication study b ð2Þ ðlÞ and the RR Both lfdr ð1Þ and g ð2Þ are the posterior probabilities, which depend on the distribution of the underlying true effect size value l.
We need to specify a prior distribution of l for the calculation of lfdr ð1Þ and g ð2Þ . In the following section, we will use a twocomponent mixture prior for l to derive their calculation formulas.
Estimation of RR
In each study, the log(OR) estimator b l ðjÞ is asymptotically normally distributed with a mean l and a standard deviation r ðjÞ , i.e.
b l ðjÞ À l r ðjÞ $ Nð0; 1Þ:
The true effect size l is unknown. Research on heritability decomposition [19] and effect size distribution [20] suggests that SNPs with small effect sizes occupy a larger proportion of the associated SNPs than those with large effect sizes. Hence, a natural prior for the effect size of the associated SNPs is a Gaussian prior with mean zero. As we do not know whether an arbitrary SNP is associated, we use the following two-component mixture prior for all SNPs:
where d 0 is the distribution with point mass on zero whose probability density function (pdf) is Dirac function dðxÞ. 
where /ðxÞ is the pdf of the standard normal distribution. 
where UðxÞ is the cumulative density function (cdf) of the standard normal distribution. When summary statistics of the primary study are available, we can approximate the asymptotic standard error of b l ð2Þ by substituting the observed allele frequencies from the primary study into Woolf's method: 
Clearly, RR, lfdr ð1Þ and g ð2Þ depend on parameters p 0 and r 0 .
As we assume all SNPs share the same distribution structure in terms of effect size in Equation (9), we can estimate the parameters with the test statistics of the primary study. The estimation of p 0 has been addressed in the literature of false discovery rate control from the Bayesian point of view [21] . Suppose there is a 'zero assumption' that all SNPs with P-value > c have almost no chance to be truly associated SNPs. Let us denote the number of those SNPs as m þ ðcÞ. Then its expectation is
which introduces an p 0 estimator
There is a trade-off between bias and variance when choosing c in the estimation of p 0 . Storey and Tibshirani [21] proposed a procedure without tuning the parameter c. The automated procedure will evaluate p 0 at different c. Then, a natural cubic spline will fit to those evaluated values. We obtain the final p 0 at c ¼ 1 of the fitted spline.
With the estimated p 0 , we estimate r 
By plugging p 0 and r 2 0 into Equations (7), (10) and (11), we obtain an RR estimator. For each primary association, we can use bootstrap method to obtain the confidence interval of RR.
Applications of RR
We will describe the two potential applications of RR in this subsection.
Determine the sample size of the replication study
Traditional sample size determination is based on power calculation. We need to specify a minimum detectable effect size (l min ) beforehand. Then, we determine the sample size such that the calculated statistical power is larger than a threshold, e.g. b ð2Þ ðl min Þ > 80%. This traditional power-based sample size determination method treats the primary study and the replication study separately. The connection between the primary and replication studies is not used in the design. Also, the specified l min may be arbitrary, and bias may occur in the specification of l min . These factors make the determined sample size subjective.
In the design of a replication study, the main question we need to consider is how many primary associations will be replicated in the study with a given sample size? Power does not directly address this question. For example, b ð2Þ ðl min Þ ¼ 80%
does not mean that 80% of primary associations can be replicated. We define the expected proportion of primary associations being validated in the replication study as the global replication rate (GRR), i.e.
GRR ¼ Pðsgnðz 
where S ¼ fijjz ð1Þ i j > z a1=2 g is the index set of primary associations. We use the subscript i to denote the SNP index. GRR is a comprehensive measure directly addressing the question of replication. Also, the connection between the primary and replication studies is used in the GRR's definition. It is more natural for us to determine the sample size of the replication study based on GRR.
Clearly, there is a relationship between GRR and RR:
where jSj is the cardinality of S. Please note that RR is a monotonic increasing function of n ð2Þ . After we set an expected replicability for primary associations, we can use the mean value of RR to determine the sample size needed in the replication study by the bisection method.
Check the consistency between the results of the primary and replication studies
After the replication study has been done, we can use RR to check the consistency between the results of the primary study and those of the replication study. Under normal situations, the results of the replication study are consistent with RR values. If inconsistency occurs, we should be alarmed, and we need to analyze the potential sources of inconsistency. These sources may be attributed to factors influencing either the primary study's or replication study's results, such as bias and measurement errors [10] . We can use the Hosmer-Lemeshow test [13] to check the consistency. The detailed steps are as follows:
1. We partition primary associations into groups according to RR. Each group has associations with approximately equal size. Let us take an example with 10 groups. The first group refers to 1/10 of the associations having the highest RR, while the second group refers to the next 1/10 of the associations having the second decile of RR, and so on. 2. We call the proportion of the replicable associations in each group the group's replication proportion (RP). We regard the mean value of RR as the group's RR. 3. We use HL to denote the test statistic of the HosmerLemeshow test. We calculate the HL by comparing RP and RR in each group:
where G is the number of groups, g is the group index and m g is the number of primary associations in group g.
1.
The null hypothesis is that the results of the replication study are consistent with the RR values. We compute the P-value using the parametric bootstrap method. That is, we resample the replication status for each primary association according to RR, and then we calculate HL again. This resampling trial is repeated R times. The P-value is the proportion of resampling trials in which HL is greater than or equal to the original HL value. 2. If the P-value is smaller than the significance level, then we reject the null hypothesis. In other words, the results of the primary and the replication studies are inconsistent, and we need to analyze the potential sources of the inconsistency.
Software
We create an R package called RRate, available at http://bioinfor matics.ust.hk/RRate.html. The package contains the following functions:
1. repRateEst(): to estimate the RR for each association discovered from the primary study. 2. repSampleSizeRR(): to determine the sample size of the replication study for a desired GRR value. 3. HLtest(): to check the consistency between the results of the primary study and those of the replication study.
We can use the following R code (repRateEst function) to estimate the RR in a simulation data set with 10 000 SNPs and 4000 individuals (2000 controls and 2000 cases) in the primary study. The sample size in the replication study is 2000 (1000 controls and 1000 cases). The significance levels in two studies are 5 Â 10 À6 and 5 Â 10 À3 , respectively. We use loose significance levels here because the number of SNPs in the example data set is small. We can use the repSampleSizeRR and HLtest functions to determine the sample size of the replication study and to check the consistency between the results of the primary and replication studies.
Performance and applications of the RR with simulation and real data Simulation
We use simulation experiments to answer the following questions:
1. Can the estimated RR predict whether a primary association will be replicated or not? 2. Is the estimated RR well calibrated as the replication probability?
We simulate 5000 controls and 5000 cases in the primary study, and 2500 controls and 2500 cases in the replication study. The number of SNPs is 1 Â 10 6 . The effect sizes of all SNPs are generated from the following two-component distribution:
The minor allele frequencies are randomly simulated from a uniform distribution U(0.05,0.5), and the prevalence of the disease is set to 1%. We use a 1 ¼ 5 Â 10 À8 and a 2 ¼ 5 Â 10 À5 as significance levels in the primary study and replication study, respectively. Here we use a conservative significance level in the replication study just because we need a number of nonreplicable associations to demonstrate the performance of the estimated RR. The method is applicable to any significance level. Figure 1 shows the comparison between RR and their true values. The two scatter plots show that RR work well in terms of estimation accuracy. This kind of experiment has been run five times. The root mean square error of RR in Table 2 shows that RRs have high estimation accuracy. We also present the estimated values of parameters (p 0 and r 2 0 ) in this table. To see whether the estimated RR can predict the replication status well, we use RR as a score to predict whether the association can be replicated or not. We draw the receiver operator characteristic (ROC) curve (Figure 2A ) using different thresholds in the prediction. A high RR value predicts that the association will be replicated. The area under the curve (AUC) is 0.858 in this simulation. This large area indicates that RR has good prediction performance as an index of replicability. In comparison, if we use the P-value as an index describing replicability, a low P-value predicts that the primary association is replicable. The AUC is 0.848, smaller than the AUC of RR. Table 3 shows the comparison of AUC in each run. The AUC of RR is larger than the AUC of P-value in all runs.
We use the group partition procedure (Steps 1 and 2 in 'Check the consistency between the results of the primary and replication studies' subsection) to see whether the estimated RR calibrates the replication probability well. We partition the primary associations into 10 groups according to RR. Figure 2B shows a comparison between RR and RP for the 10 groups, and we can see that these two quantities agree well. The correlation between them is 0.999. This result implies RR is well calibrated as the replication probability.
We can use RR to determine the sample size needed in the replication study to achieve an expected replicability. Figure 3 plots the estimated GRR for different sample size ratios n ð2Þ =n ð1Þ (from 0.5 to 1.5). For each sample size ratio, we simulate a data set as the replication study. We call the realized proportion of primary associations being replicated the global replication proportion (GRP). We also plot GRP for different sample size ratios in Figure 3 . From the figure, we can see that GRR and GRP agree well. If we want 80% of primary associations to be replicated, we need to collect about 0:5n ð1Þ ¼ 5000 individuals in the replication study. We can also use RR to check the consistency between the results of the primary study and those of the replication study. We use the Hosmer-Lemeshow test to accomplish this task. The test statistic in this simulation experiment is 14.460, and the corresponding P-value is 0.105. The results of the primary and replication studies are therefore consistent.
To check whether RR estimation has good performance in the phenotype with different genetic architecture, we also apply RR estimation to simulated data with different effect size distribution: 
and l $ 0:95d 0 þ 0:03Nð0; 0:0064Þ þ 0:02Nð0; 0:04Þ;
where t 5;0:2 is a scaled t-distribution with degree of freedom 5 and scaling factor 0.2. In the first case, effect sizes of true associated SNPs are weak, which is a common case in a number of psychiatric disorders [22] . In the second case, effect sizes of associated SNPs follow heavy-tail distribution. In the third case, the distribution of associated SNPs' effect sizes is a mixture of weak effect and strong effect. Figure 4 shows ROC curves and the RP-RR plot for three cases. Table 4 presents corresponding AUC values in each run. In the first case, prediction performances of RR and P-value are similar. In other two cases, RR performs better than P-value in terms of prediction. Calibration performances of RR are good in all three cases. The well-calibration of RR implies that we can use RR to determine sample size of the replication study and to check the consistency between results of the primary and replication studies.
To check the performance of RR estimation when independent assumption is violated, we use GWAsimulator [23] to generate genotype data of the individuals in the general population based on haplotype distributions from the HapMap Northern and Western Europeans from Utah (CEU) samples. We simulate m ¼ 314 174 SNPs which are on Illumina HumanHap300 chip, in which 15 of them are chosen as disease loci. For each disease loci, we use multiplicative model as disease model and the relative risk for heterozygotes is 2. We simulate 5000 controls and 5000 cases in the primary study, and 2500 controls and 2500 cases in the replication study. Figure 5 shows ROC curves and the RP-RR plot. Table 5 presents AUC values in 5 runs. In this situation, RR has similar prediction performance to P-value. However, RR is wellcalibrated as the replication probability.
Real data

T2D data from DIAGRAM
We use the public T2D data set from DIAGRAM (http://diagram-con sortium.org/) to further check RR prediction and calibration performance. We use GWAS meta-analysis (DIAGRAMv3) as the Figure 2 . RR has good prediction and calibration performance in the simulation study. (A) We use RR and the P-value as scores to predict the replicated/non-replicated status in the replication study. We draw the corresponding ROC curves. The x-axis gives the false-positive rate in the replicability prediction, and the y-axis gives the corresponding true-positive rate. The AUC is the area under the ROC curve. RR has better prediction performance than the P-value. (B) We partition primary associations into 10 groups according to RR. The x-axis gives the RR of the group, which is the mean value of RR within the group. The y-axis gives the corresponding RP of the group, which is the proportion of the replicated associations in each group. The solid line is y ¼ x. The correlation coefficient between RR and RP is 0.999. RR is wellcalibrated. A colour version of this figure is available at BIB online: https://academic.oup.com/bib. We use RR and P-value as an index describing replicability, respectively. A value in bold indicates that this value has higher AUC value in this run. GRR and GRP for different sample size ratios n ð2Þ =n ð1Þ in the simulation experiment. We estimate GRR using summary statistics from the primary study. For each sample size ratio, we simulate a data set as the replication study. GRP is the realized proportion of primary associations being replicated. GRR and GRP agree well in the experiment. A colour version of this figure is available at BIB There are 166 SNPs showing significant associations with T2D in the primary study and genotyped in the replication study. The GRP is 91.6%. We show the estimated RR results of these SNPs in Supplementary Table 1 (http://bioinformatics.ust.hk/ RRate.html). The estimated GRR is 90.6%, which is close to GRP. We draw the ROC curve for the prediction of replicability based on RR ( Figure 6A ). The AUC is 0.833. In comparison, if we use the P-value as an index predicting replicability, then the AUC is 0.762, smaller than the AUC of RR. (20)- (22), the prediction and calibration performance of RR. (A), (C) and (E) show ROC curves of RR and P-value when effect sizes follow Equations (20), (21) and (22) To see whether the estimated RR is well-calibrated as the replication probability, we partition all primary associations into five groups according to their RR values. Then we make a comparison between RR and RP in each group. We use five groups here instead of the 10 groups used in the simulation study because the number of primary associations is much smaller than the number of associations in the simulation experiments. Figure 6B shows the comparison between RR and RP. These two quantities agree well, with the correlation between them being 0.986. This result illustrates that RR has a good calibration performance.
We can use RR to determine the sample size of the replication study to achieve an expected number of replicable associations. We plot the estimated GRR for different sample size ratios n ð2Þ =n ð1Þ (from 0.5 to 1.0) in Figure 7 . If we want 80% of primary associations to be replicated, we need about 0:9n ð1Þ ¼ 62 130 individuals in the replication study. We can use the Hosmer-Lemeshow test to check the consistency between the results of the primary and replication studies. The test statistic is 1.559, and the corresponding P-value is 0.812. The results of the primary and replication studies are therefore consistent.
TC data from GLGC
We also conducted experiments using published TC data from GLGC (http://csg.sph.umich.edu//abecasis/public/lipids2013/).
The phenotype value measured in the study is quantitative, and we use the standardized regression coefficients as the test statistics. We use GWAS meta-analysis, comprising 94 595 individuals, as the primary study. The SNP number is m ¼ 1 362 710. We use metabochip study, comprising 93 982 individuals, as the replication study. After filtering out SNPs with P-value < 0. 01 in homogeneity test, there are 48 064 SNPs remaining in the replication study. The significance levels in the primary and replication studies are 5 Â 10 À8 and 5 Â 10 À5 , respectively.
The estimated proportion of null hypotheses is b p 0 ¼ 0:951, and the estimated effect size variance is b r The GRP is 88.9%. We show the estimated RR results of these SNPs in Supplementary Table 2 (http://bioinformatics.ust.hk/ RRate.html). The estimated GRR is 89.9%, which is close to GRP. We draw the ROC curve for the prediction of replicability based on RR ( Figure 8A ). The AUC is 0.871. In comparison, if we use the P-value as an index predicting replicability, then the AUC is 0.828, smaller than the AUC of RR.
To see whether the estimated RR has good calibration performance, we partition the primary associations into five groups according to their estimated RR values. Then we make a comparison between RR and RP in each group. Figure 8B shows the good agreement between RR and RP in the five groups. The correlation coefficient is 0.993. Case 1: effect sizes follow the distribution of Equation (20); Case 2: effect sizes follow the distribution of Equation (21); Case 3: effect sizes follow the distribution of Equation (22) . A value in bold indicates that this value has higher AUC value in this run. We can use RR to determine the sample size of the replication study, and we plot GRR for different sample size ratios n ð2Þ =n ð1Þ in Figure 9 . If we want 80% of primary associations to be replicated, we need about 0:76n ð1Þ ¼ 71 892 individuals in the replication study. We can use the Hosmer-Lemeshow test to check the consistency between the results of the primary and replication studies. The test statistic is 4.682, and the corresponding P-value is 0.29. The results of the primary and replication studies are therefore consistent.
Discussion
Please note that if lfdr ð1Þ > 0, which is usually the case for a primary positive association, RR has an upper limit which is <1. According to Equation (7) 
where equality is achieved if g ð2Þ ¼ 1. The influence of the null distribution (namely a 2 =2) never disappears for a primary positive association with lfdr ð1Þ > 0. The Bayesian predictive power g ð2Þ can be increased by increasing the sample size of the replication study. In the situation of lfdr ð1Þ > 0, no matter how many individuals participate in the replication study, the primary association will not have 100% probability of being replicated. There is also an upper bound for GRR according to Equation (17):
If a 1 is stringent enough, lfdr ð1Þ is small for each primary association. In this situation, the upper bounds of RR and GRR are close to 1. We normally use an unbiased testing method, i.e. a 2 =2 g ð2Þ . Hence, we have RR g ð2Þ according to Equation (7).
This indicates that the probability of a primary association being replicated is smaller than the Bayesian predictive power of the replication study. Normally, lfdr ð1Þ is controlled by using stringent significance level a 1 , and a 2 is a small value. RR and g ð2Þ are close to each other in this situation.
At first glance, one may regard the P-value as a quantitative index of replicability. A statistically significant association with a lower P-value has a higher possibility of being replicated than an association with a higher P-value. The argument is that the P-values of associations have the same ordering as the lfdrs, which are the probabilities of the corresponding hypotheses being true null hypotheses given their test statistics. But a low probability of being null hypotheses does not mean a high probability of being replicated. Hence, unlike RR, the P-value is not directly an index of replicability.
Claiming an association to be replicated depends on the significance level of the replication study a 2 . For primary associations, estimated RR values also depend on a 2 . We present experiment results for a 2 ¼ 5 Â 10 À4 and a 2 ¼ 5 Â 10 À6 on our Web site (http://bioinformatics.ust.hk/RRate.html). From Equations (7) and (11), RR is a monotonic increasing function of a 2 . This is consistent with our intuition: the more stringent threshold we set, the less primary associations will be replicated. RR also depends on parameters p 0 and r 2 0 among all SNPs. From Equations (7) and (10), RR is a monotonic decreasing function of p 0 . This is because the increase of p 0 reduces the probability of each primary association being true associated one. From Equations (7), (10) and (11), RR is a monotonic increasing function of r In some GWASs, the number of detected primary associations is small. This may be attributed to large value of p 0 and/ or small value of r 2 0 . In either case with a given n ð2Þ , RR is small.
We need large sample size in the replication study to replicate primary associations with adequate RR. As we use the replication status of each primary association as an observation in our consistency checking method, there is no enough number of observations when only a few primary associations are detected. Hence, our consistency checking method has no enough power to detect inconsistency between results in this situation.
The accuracy of RR estimation relies on the accuracy of b p 0 . Although we apply the method of Storey and Tibshirani [21] to estimate p 0 , there exist other options. For example, when the 'zero assumption' is violated in data or the true null distribution of test statistics does not agree with the theoretical distribution [24] , it may be better to use the methods proposed by Langaas et al. [25] or Jin and Cai [26] for a reliable estimation of p 0 .
Our method can be directly generalized to any tests within z-test scheme and with closed-form expression for standard error of effect size, such as log(OR) test, regression slope test and the Cochran-Armitage trend test [27] . For other tests within z-test scheme but without closed-form expression for standard error of effect size, we have problem in estimating r ð2Þ .
However, if control-to-case ratios are the same in the primary and replication studies, then we can approximate r 
In this case, we can use our method to estimate RR directly. The current model of RR is limited by the independence assumption between SNPs. In reality, correlations between SNPs, such as linkage disequilibrium, are common. An adjusted model for RR considering correlation is needed in the future.
Our current model of RR is limited to z-test scheme in singlemarker test. Recent developments in sequencing technique have extended targets of association studies to both common variants and rare variants. Single-marker test is underpowered in detecting rare variants. To deal with this issue, a lot of multimarker test and collapsing tests are proposed [28, 29] . Adjusted models for RR calculation with these testing methods are needed in the future. Figure 8 . RR has good prediction and calibration performance in TC data from GLGC. (A) We use RR and the P-value to predict the replication status of primary associations, respectively. We draw their ROC curves in the figure. According to their AUC values, RR has better prediction performance than the P-value. (B) We partition primary associations into five groups according to RR. The x-axis gives the RR of the group, and the y-axis gives the corresponding RP of the group. The solid line is y ¼ x.
RR is well calibrated. A colour version of this figure is available at BIB online: https://academic.oup.com/bib. Figure 9 . GRR for different sample size ratios n ð2Þ =n ð1Þ in TC data from GLGC. We use the summary statistics from the primary study to estimate GRR for different sample size ratios. A colour version of this figure is available at BIB online:
https://academic.oup.com/bib.
Conclusion
In GWASs, statistically significant associations identified in a primary study need to be validated in a replication study. In this article, we present a Bayesian framework to systematically study the behavior of those primary associations in the replication study. RR is a probabilistic measure to quantify that behavior. We describe an estimation method for RR based on the summary statistics of the primary study. We can use RR to determine the sample size of the replication study and to check the consistency between the results of the primary study and those of the replication study. We describe an R-package to estimate and apply RR in GWASs. Experiments using simulation and real data show the estimation results can accurately predict the replicability and is well calibrated. They also demonstrate the usefulness of RR.
Key Points
• In GWAS, positive findings often need to be validated by replication studies.
• RR refers to the Bayesian probability of replicating a positive finding from the primary study.
• Before collecting the replication study, we can use RR to determine the sample size of the replication study.
• After the collection, we can use RR to check the consistency between the results of the primary study and those of the replication study.
